|
Cardiac Science has initiated a worldwide voluntary recall after determining that approximately 12,200 automated external defibrillators (AEDs) may not be able to deliver therapy during a resuscitation attempt, which may lead to serious adverse events or death.
Written by Chris Knight
How do you realize the value of a human life? There are many ways really, but for me the true clarity came from my death. Yes, that’s right, I died; five times to be exact. My name is Chris Knight, and because of a miraculous second chance at life, I am taking this opportunity to share with you my story.
Cardiac Science has reported net losses for the fourth quarter and the full year of 2008. The company also named Dave Marver as a replacement for CEO and president John Hinson, who is leaving "for personal reasons."
Cardiac Science, a provider of cardiac diagnosis, resuscitation, rehabilitation and informatics products, launched its fourth generation Burdick HeartStride exercise stress system at the American Heart Association (AHA) Scientific Sessions last week.
Cardiac Science, a provider of cardiac diagnosis, resuscitation, rehabilitation and informatics products, announced revenue for the quarter ended Sept. 30, of $54 million, an increase of 20 percent over the $45.1 million in revenue in the prior year period.
|
The FDA has issued warnings for Cardiac Science’s Powerheart and CardioVive automated external defibrillator (AED) G3 series, manufactured between August 2003 and August 2009, for the possibility of malfunction during use.
The global electrocardiography (ECG) market is expected to reach $157.9 million in 2015 with an annual growth rate of 3.7 percent, compared with a market valued at $122.2 million in 2008, according to estimates from market research firm GlobalData.
Cardiac Science, a provider of cardiac diagnosis, resuscitation, rehabilitation and informatics products, plans to reduce its current staff by approximately 12 percent and cut other expenses.
Cardiac Science, a provider of cardiac diagnosis, resuscitation, rehabilitation and informatics products, reported that its board of directors accepted the resignation of two directors, and appointed a new director, at its regularly scheduled meeting last week. As a result of the changes, the total number of directors on the board will be seven.
Cardiac Science, a provider of advanced cardiac diagnosis, resuscitation, rehabilitation and informatics products, has launched its new Quinton Q-Stress 4.0, a ninth generation diagnostic stress testing technology, and Quinton Q-Tel RMS 3.1, an electronic reporting system.
|